BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35014044)

  • 1. Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications.
    Hassan S; Meenatchi R; Pachillu K; Bansal S; Brindangnanam P; Arockiaraj J; Kiran GS; Selvin J
    J Basic Microbiol; 2022 Sep; 62(9):999-1029. PubMed ID: 35014044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.
    Bajpai VK; Shukla S; Kang SM; Hwang SK; Song X; Huh YS; Han YK
    Mar Drugs; 2018 May; 16(6):. PubMed ID: 29882898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-Art Extraction Methodologies for Bioactive Compounds from Algal Biome to Meet Bio-Economy Challenges and Opportunities.
    Sosa-Hernández JE; Escobedo-Avellaneda Z; Iqbal HMN; Welti-Chanes J
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30424551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for green microalgae to produce hydrogen, pharmaceuticals and other high value products in a combined process.
    Skjånes K; Rebours C; Lindblad P
    Crit Rev Biotechnol; 2013 Jun; 33(2):172-215. PubMed ID: 22765907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Algal-derived Bioactive Compounds in Human Health.
    Tripathi G; Dubey P; Ahmad S; Farooqui A; Mishra V
    Recent Pat Biotechnol; 2024; 18(3):190-209. PubMed ID: 37537776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive substances of cyanobacteria and microalgae: Sources, metabolism, and anticancer mechanism insights.
    Bouyahya A; Bakrim S; Chamkhi I; Taha D; El Omari N; El Mneyiy N; El Hachlafi N; El-Shazly M; Khalid A; Abdalla AN; Goh KW; Ming LC; Goh BH; Aanniz T
    Biomed Pharmacother; 2024 Jan; 170():115989. PubMed ID: 38103309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seaweed Bioactive Compounds against Pathogens and Microalgae: Potential Uses on Pharmacology and Harmful Algae Bloom Control.
    Zerrifi SEA; El Khalloufi F; Oudra B; Vasconcelos V
    Mar Drugs; 2018 Feb; 16(2):. PubMed ID: 29425153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symbioses of Cyanobacteria in Marine Environments: Ecological Insights and Biotechnological Perspectives.
    Mutalipassi M; Riccio G; Mazzella V; Galasso C; Somma E; Chiarore A; de Pascale D; Zupo V
    Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33923826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive Molecules from Marine Diatoms and Their Value for the Nutraceutical Industry.
    Nieri P; Carpi S; Esposito R; Costantini M; Zupo V
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine Bacteria versus Microalgae: Who Is the Best for Biotechnological Production of Bioactive Compounds with Antioxidant Properties and Other Biological Applications?
    Hamidi M; Kozani PS; Kozani PS; Pierre G; Michaud P; Delattre C
    Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31905716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalgae for High-Value Products Towards Human Health and Nutrition.
    Barkia I; Saari N; Manning SR
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31137657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative Bioactive Products with Medicinal Value from Microalgae and Their Overall Process Optimization through the Implementation of Life Cycle Analysis-An Overview.
    Papadaki S; Tricha N; Panagiotopoulou M; Krokida M
    Mar Drugs; 2024 Mar; 22(4):. PubMed ID: 38667769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalgal bioactive metabolites as promising implements in nutraceuticals and pharmaceuticals: inspiring therapy for health benefits.
    Kaur M; Bhatia S; Gupta U; Decker E; Tak Y; Bali M; Gupta VK; Dar RA; Bala S
    Phytochem Rev; 2023 Jan; ():1-31. PubMed ID: 36686403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.
    Qamar H; Hussain K; Soni A; Khan A; Hussain T; Chénais B
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalgae Encapsulation Systems for Food, Pharmaceutical and Cosmetics Applications.
    Vieira MV; Pastrana LM; Fuciños P
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33333921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalgae/cyanobacteria: the potential green future of vitamin B
    Durdakova M; Kolackova M; Janova A; Krystofova O; Adam V; Huska D
    Crit Rev Food Sci Nutr; 2024; 64(10):3091-3102. PubMed ID: 36222060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Review of Microalgae and Cyanobacteria-Based Biostimulants for Agriculture Uses.
    Chabili A; Minaoui F; Hakkoum Z; Douma M; Meddich A; Loudiki M
    Plants (Basel); 2024 Jan; 13(2):. PubMed ID: 38256713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our Future.
    Mazard S; Penesyan A; Ostrowski M; Paulsen IT; Egan S
    Mar Drugs; 2016 May; 14(5):. PubMed ID: 27196915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Applications for Protein and Compounds from Microalgae.
    Castiglia D; Landi S; Esposito S
    Plants (Basel); 2021 Aug; 10(8):. PubMed ID: 34451730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Algal chemodiversity and bioactivity: sources of natural variability and implications for commercial application.
    Stengel DB; Connan S; Popper ZA
    Biotechnol Adv; 2011; 29(5):483-501. PubMed ID: 21672617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.